| Literature DB >> 28003017 |
E Kieckens1,2, J Rybarczyk3,4, R W Li5, D Vanrompay4, E Cox3.
Abstract
BACKGROUND: Enterohaemorrhagic Escherichia coli (EHEC), like E. coli O157:H7 are frequently detected in bovine faecal samples at slaughter. Cattle do not show clinical symptoms upon infection, but for humans the consequences after consuming contaminated beef can be severe. The immune response against EHEC in cattle cannot always clear the infection as persistent colonization and shedding in infected animals over a period of months often occurs. In previous infection trials, we observed a primary immune response after infection which was unable to protect cattle from re-infection. These results may reflect a suppression of certain immune pathways, making cattle more prone to persistent colonization after re-infection. To test this, RNA-Seq was used for transcriptome analysis of recto-anal junction tissue and ileal Peyer's patches in nine Holstein-Friesian calves in response to a primary and secondary Escherichia coli O157:H7 infection with the Shiga toxin (Stx) negative NCTC12900 strain. Non-infected calves served as controls.Entities:
Keywords: Cattle; Escherichia coli O157:H7; Immunosuppression; RNA-Seq
Mesh:
Year: 2016 PMID: 28003017 PMCID: PMC5178093 DOI: 10.1186/s12864-016-3374-y
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Experimental setup
Fig. 2Average faecal excretion of infected animals. Error bars indicate standard deviations. Arrows on the x-axis indicate the timepoint of first and second infection
Transcript abundance in the recto-anal junction and Ileal Peyer’s patches
| Transcript category | Recto-anal junction | Ileal Peyer’s patches |
|---|---|---|
| Not expressed | 11.17% | 10.18% |
| Very rare | 70.68% | 70.55% |
| Rare | 16.18% | 17.29% |
| Moderately abundant | 1.74% | 1.78% |
| Abundant | 0.23% | 0.21% |
Fig. 3Venn diagram of differentially expressed genes in the recto-anal junction
Overview of numbers of up- and downregulated genes in respect to their effect on the immune system
| Immune stimulating effect | Immune suppressive effect | |||
|---|---|---|---|---|
| # upregulated | # downregulated | # upregulated | # downregulated | |
| Recto-anal junction | / | 2 | 1 | / |
| Ileum + PP | 25 | 67 | 6 | 5 |
Fig. 4Venn diagram of differentially expressed genes in ileal Peyer’s patches
Fig. 5Regulatory network related to antimicrobial response impacted in the ileal Peyer’s patches of calves after a primary infection with E. coli O157:H7. Up- and downregulation is represented by green and red colours, respectively
Fig. 6Regulatory network related to inflammatory response impacted in the ileal Peyer’s patches of calves after a primary infection with E. coli O157:H7. Up- and downregulation is represented by green and red colours, respectively
Fig. 7Regulatory network related to infectious disease impacted in the ileal Peyer’s patches of calves after a primary infection with E. coli O157:H7. Up- and downregulation is represented by green and red colours, respectively
Gene expression results for recto-anal junction samples with fold change >2
| Gene namea | Gene function | Fold change | Reference |
|---|---|---|---|
| KLRJ1 + (Ly49) | Natural killer cell receptor binding host MHC I as a mechanism of self/health recognition. Binding of the ligand results in an inhibitory signal to prevent killing of the target cell. | −3.89971 | Storset et al. (2003) [ |
| MARCO− | Innate immune defense. Can bind Gram-negative bacteria to stimulate clearing of the pathogen. | 3.68421 | Elomaa et al. (1998) [ |
| CCL20− | Strongly chemotactic for lymphocytes and weakly for neutrophils. | 3.33712 | Mohammed et al. (2007) [ |
a: + = upregulated; − = downregulated
Gene expression results for Ileal Peyer’s patches samples with fold change >2
| Gene Namea | Gene function | Fold change | Reference |
|---|---|---|---|
| ENPP7+ | Might have an inflammatory effect, as it could degrade and inactivate platelet-activating factor (PAF). | −9.92813 | Wu et al. (2006) [ |
| PDIA2+ | Helps to load antigenic peptides into MHC I molecules and is therefore important in antigen recognition and clearing. | −4.4116 | LeBrasseur (2006) [ |
| BT.36112+ | (KIR) Killer cell immunoglobulin receptor suppresses the cytotoxic activity of NK cells. | −2.92833 | Vilches et al. (2002) [ |
| MGC137099+ | Is preferentially expressed on Th2 cells and is together with SEMA4A a stimulatory molecule for T-cell activation. | −2.54481 | European bioinformatics institute (2015) [ |
| PRLR+ | Cytokine receptor and important in the JAK-STAT, JAK-RUSH, Ras-Raf-MAPK and PI-3 K pathways. | −2.47279 | Bouchard et al. (1999) [ |
| LY6G6E+ | Possible role of Ly-6 family members in T-cell activation, differentiation and maturation (mouse studies) | −2.4165 | Mallya et al. (2006) [ |
| BTRAPPIN-5+ | Multifunctional host-defense peptide with anti-proteolytic, anti-inflammatory and anti-microbial activities. | −2.25014 | Kato et al. (2010) [ |
| SUSD2+ | Contributes to evasion of immune responses by induction of apoptosis in activated T-cells | −2.24943 | Watson. (2011) [ |
| KLRJ1+ | (see Table | −2.04608 | Storset et al. (2003) [ |
| FCRLA− | Leading to inflammatory responses and antibody-mediated cellular cytotoxicity. | 7.21319 | Inozume et al. (2007) [ |
| CXCL13− | Chemokine B-lymphocyte chemoattractant. | 6.63854 | Legler et al. (1998) [ |
| DEFB5− | Bovine neutrophil β-defensins exert broad spectrum of antimicrobial activities against several species that cause mastitis as | 6.0118 | Alnakip et al. (2014) [ |
| BT.53744− | Development and differentiation of B-cells into plasma cells. | 6.01462 | International Molecular Exchange Consortium (2015) [ |
| TNFRSF13C− | Mature B-cell survival. | 5.9961 | Thompson et al. (2001) [ |
| CD79B− | Initiation of the signal transduction cascade activated by the B-cell antigen receptor complex which will lead to antigen presentation. | 5.81055 | Luisiri et al. (1996) [ |
| SRCRB4D− | Regulation of innate and adaptive immune responses. | 5.45381 | OMIM database (2004) [ |
| CD180− | Controls B-cell recognition and signaling of LPS. | 4.59918 | NCBI Reference Sequence Database (2008) [ |
| FCRL1− | Functions in B-cell activation and differentiation. | 4.43127 | Gauld et al. (2002) [ |
| CLEC4E− | Induces secretion of inflammatory cytokines after binding of ligands (such as damaged cells, funghi and microbacteria). | 4.4039 | Miyake et al. (2010) [ |
| CXCR5− | Chemokine plays an essential role in B-cell migration. | 4.00308 | Sáez de Guinoa et al. (2011) [ |
| CD19− | Acts as a B-cell coreceptor in conjunction with CD21 and CD81. | 3.8374 | Van Zelm et al. (2006) [ |
| P2RY8− | Regulator of the immune response. | 4.05228 | Amisten et al. (2007) [ |
| LTA− | Mediates a large variety of inflammatory, immunostimulatory and antiviral responses. | 3.70982 | NCBI Reference Sequence Database (2012) [ |
| CXCR4− | Receptor for SDF-1, has potent chemotactic activity for lymphocytes. | 3.67364 | Tamamis et al. (2014) [ |
| TLR10− | Role in pathogen recognition and activation of innate immunity. | 3.64532 | Lee et al. (2014) [ |
| SPP1− | Chemotactic for many cell types including macrophages, dendritic cells and T cells; it enhances B lymphocyte immunoglobulin production and proliferation. In inflammatory situations it stimulates both pro- and anti-inflammatory processes. | 3.49813 | Wang et al. (2008) [ |
| BANK1− | Is expressed during development of B-lineage cells. | 3.34384 | Dymecki et al. (1992) [ |
| FCRL3− | Regulator of the immune system. | 3.32282 | Swainson et al. (2010) [ |
| LTB− | LTs are important for innate and adaptive immune responses by controlling the expression of several adhesion molecules, other cytokines and chemokines | 2.50217 | Creus et al. (2012) [ |
| DOK3− | Negative regulator of JNK signaling in B-cells. | 3.02771 | Robson et al. (2004) [ |
| KLRF1− | Activating lectin-like receptor expressed on NK-cells and stimulates their cytotoxicity and cytokine release. | 3.00125 | Kuttruff et al. (2009) [ |
| FCER2− | Transportation in antibody feedback regulation | 2.85172 | Kijimoto-Ochiai (2002) [ |
| FCAMR− | is expressed constitutively on the majority of B-lymphocytes and macrophages; FCAMR functions as a receptor for the Fc fragment of IgA and IgM and binds IgA and IgM with high affinity and mediates their endocytosis | 2.82211 | Shibuya et al. (2000) [ |
| CCL19− | Antimicrobial gene; may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs | 2.54095 | National Center for Biotechnology Information Gene (2014) [ |
| TNFSF8− | Involved in cell differentiation, apoptosis and immune response | 2.43376 | Wei et al. (2011) [ |
| SOCS1− | Negative regulator of cytokine signaling. | 2.33913 | Krebs et al. (2011) [ |
| TIMD4− | Enhances the engulfment of apoptotic cells: involved in regulating T-cell proliferation and lymphotoxin signaling. | 2.304 | Uniprot (2015) [ |
| SIT1− | Negatively regulates T-cell receptor mediated signaling in T-cells. | 2.28439 | Marie-Cardine et al. (1999) [ |
| BDKRB1− | Receptor binding leads to increase in the cytosolic calcium ion concentration, resulting in chronic and acute inflammatory responses. | 2.26204 | Talbot et al. (2012) [ |
| AKAP5− | Is expressed in T-lymphocytes and may function to inhibit IL-2; IL-2 is part of the body’s natural responses to microbial infections. | 2.20946 | Schillace et al. (2002) [ |
| PGLYRP2− | Recognizes peptidoglycan, a component of bacterial cell walls. | 2.19916 | Dziarski et al. (2010) [ |
| CD37− | T-cell and B-cell interactions. | 2.13192 | Knobeloch et al. (2000) [ |
a: + = upregulated; − = downregulated
Duration of infection after primary or re-infection with NCTC12900 strain
| Duration of infection | Primary infection ( | Re-infection ( |
|---|---|---|
| 0–7 days | 9 | 0 |
| 7–14 days | 23 | 5 |
| 14–21 days | 0 | 4 |
| 21–28 days | 0 | 3 |
| >28 days | 0 | 14 |